Orthopedic viewpoint: How the COVID-19 pandemic will accelerate value-based care

Carly Behm - Print  |

Spine surgeon Alok Sharan, MD, wrote about value in healthcare post-COVID-19 for the Journal of Orthopedic Experience and Innovation.

Dr. Sharan defined two eras in his article: Value 1.0 and Value 2.0. Value 1.0 starts with the publication of "Redefining Healthcare" by Michael Porter, PhD, and Elizabeth Teisberg, PhD, in 2006 through the present day. This focused on achieving value for patients, defining it as health outcomes per dollar spent.

Value 2.0 will be the time when high-value services and treatments are implemented, Dr. Sharan wrote. He pointed to four value propositions: lowering costs, providing convenient care, delivering an exceptional experience and offering the highest-quality product. 

As competition increases, providers should focus on these value propositions to give themselves a competitive advantage, he wrote.

The COVID-19 pandemic has accelerated the competition for resources, he wrote. In the orthopedic sphere, surgeons previously could have an advantage by performing a novel surgical procedure. Now, with few procedures that can be considered new, surgeons can gain a competitive advantage by embracing value propositions in their care, Dr. Sharan wrote. This transformation in care is expected to come sooner due to the pandemic.

Read the full commentary here.

More articles on surgery centers:
Ohio surgery center performs 1st robotic procedure
How has the pandemic affected patient demand across the big 3 specialties? Here's what 3 leaders say
Research on patient access in a post-COVID-19 world: 5 statistics

 

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.